Ovarian Cancer

The incidence of ovarian cancer is supposed to be sporadic, with just about 3 percent of cancers among women said to originate from the ovaries. However, it is considered more lethal than any other cancer of female reproductive system. Clovis' Slice Of Luck So when the FDA granted accelerated...

Shares of TESARO Inc (NASDAQ: TSRO) were trading higher by more than 12 percent early Monday morning after the company reported encouraging results from its niraparib Phase 3 NOVA clinical trial results. The trial was designed to assess the progression free survival rate among 553 patients...

Shares of OXiGENE Inc (NASDAQ: OXGN), a nano-cap biopharmaceutical company that focuses on the development of vascular disrupting agents for the treatment of cancer, surged higher by more than 65 percent early Tuesday morning. Investors and traders reacted to OXiGENE's announcement that the "...

AstraZeneca plc (ADR) (NYSE: AZN) announced that Lynparza, which has already received approval for ovarian cancer, failed to meet the overall survival endpoint in gastric cancer in the PII GOLD trials. Sachin Jain of Bank of America Merrill Lynch maintains a Buy rating on the company, with a price...

Johnson & Johnson (NYSE: JNJ) is being forced to pay $55 million in damages to a user of its talcum powder products. Talc is a mineral composed of magnesium, silicon, oxygen and hydrogen. According to CNN Money, Johnson & Johnson will pay $55 million in damages to Gloria Ristesund, who used...